Chemoinformaics analysis of (2S)-4-[(E)-2-(CARBOXYMETHYLAMINO)VINYL]-2,3-DIHYDROPYRIDINE-2,6-DICARBOXYLIC ACID
Molecular Weight | 268.225 | nRot | 5 |
Heavy Atom Molecular Weight | 256.129 | nRig | 9 |
Exact Molecular Weight | 268.07 | nRing | 1 |
Solubility: LogS | -1.341 | nHRing | 1 |
Solubility: LogP | -0.384 | No. of Aliphatic Rings | 1 |
Acid Count | 3 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 33.3835 |
nHD | 4 | BPOL | 16.3525 |
QED | 0.401 |
Synth | 3.298 |
Natural Product Likeliness | 0.478 |
NR-PPAR-gamma | 0.029 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.121 |
HIA | 0.348 |
CACO-2 | -6.02 |
MDCK | 0.00036942 |
BBB | 0.143 |
PPB | 0.434705 |
VDSS | 0.352 |
FU | 0.601421 |
CYP1A2-inh | 0.011 |
CYP1A2-sub | 0.033 |
CYP2c19-inh | 0.025 |
CYP2c19-sub | 0.038 |
CYP2c9-inh | 0.009 |
CYP2c9-sub | 0.134 |
CYP2d6-inh | 0.036 |
CYP2d6-sub | 0.109 |
CYP3a4-inh | 0.022 |
CYP3a4-sub | 0.008 |
CL | 1.826 |
T12 | 0.905 |
hERG | 0.019 |
Ames | 0.008 |
ROA | 0.002 |
SkinSen | 0.089 |
Carcinogencity | 0.018 |
EI | 0.162 |
Respiratory | 0.914 |
NR-Aromatase | 0.005 |
Antiviral | Yes |
Prediction | 0.516178 |